αKlotho: FGF23 coreceptor and FGF23-regulating hormone
被引:12
|
作者:
Jueppner, Harald
论文数: 0引用数: 0
h-index: 0
机构:
Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USAMassachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
Jueppner, Harald
[1
,2
]
Wolf, Myles
论文数: 0引用数: 0
h-index: 0
机构:
Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USAMassachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
Wolf, Myles
[3
]
机构:
[1] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA
[3] Univ Miami, Miller Sch Med, Div Nephrol & Hypertens, Dept Med, Miami, FL 33136 USA
Low levels of phosphate can disrupt bone ossification and predispose to fractures. FGF23 is one of the major determinants of phosphate-homeostasis, acting to increase urinary phosphate excretion. However, the regulation of FGF23 is incompletely understood. In this issue of the JCI, Smith et al. show that the cleaved form of alpha Klotho, the membrane bound form of which is an FGF23 coreceptor, serves as a novel endocrine regulator of phosphate homeostasis, capable of inducing FGF23 production in osteocytes.